← FDA Drug Approvals (Drugs@FDA)

CABERGOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS INC · Approved 2007-07-03

Drug application

FDA Application #

ANDA077843

Application type

Abbreviated New Drug Application (Generic)

Brand name

CABERGOLINE

Generic name

Cabergoline

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

IMPAX LABS INC

First approval

2007-07-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown